Hangzhou Tigermed Consulting Co., Ltd.
Hangzhou Tigermed Consulting Co., Ltd.
Certificat de dépôt · US41044T1088 (OTC)
Aperçu
Pas de cours
Cours de clôture OTC 03.11.2025: 4,00 USD
03.11.2025 21:00
Cours actuels de Hangzhou Tigermed Consulting Co., Ltd.
BourseTickerDeviseDernier échangeCoursVariation journalière
OTC: UTC
UTC
HNGZY
USD
03.11.2025 21:00
4,00 USD
0,00 USD
Profil de l'entreprise pour Hangzhou Tigermed Consulting Co., Ltd. Certificat de dépôt
Hangzhou Tigermed Consulting Co., Ltd. provides contract research organization services in the People's Republic of China and internationally. It operates in Clinical Trial Solutions, and Clinical-related and Laboratory Services segments. The company offers regulatory submission and approval, medical translation, and good manufacturing practice (GMP) consulting services; and clinical services in the areas of medical science, early clinical and late phase development, medical monitoring, project management, patient recruitment, and quality management system. It also provides biometrics services comprising data management, biostatistics, and statistical programming; and integrated technology services, such as site management, pharmacovigilance, third party audit and training, medical imaging, clinical trial system solution, central laboratory, pre-clinical, and research hospital. Further, the company offers medical device/ in vitro diagnostics (IVD) services comprising medical device testing, regulatory submission, clinical evaluation and trials, GMP certificate, EU MDR and IVDR preparation, and value-added services; and post-marketing study, real world evidence, and vaccine clinical trial services. Hangzhou Tigermed Consulting Co., Ltd. was incorporated in 2004 and is headquartered in Hangzhou, the People's Republic of China.
Obtenez des informations actualisées de finAgent sur Hangzhou Tigermed Consulting Co., Ltd.

Données de l'entreprise

Nom Hangzhou Tigermed Consulting Co., Ltd.
Société Hangzhou Tigermed Consulting Co., Ltd.
Site web https://www.tigermed.net
Marché d'origine OTC UTC
ISIN US41044T1088
Type de titre Certificat de dépôt
Secteur Healthcare
Industrie Medical - Diagnostics & Research
PDG Xiaoping Ye D.Phil, EMBA,
Capitalisation boursière 6 Mrd.
Pays Chine
Devise USD
Employés 10,2 T
Adresse F18, Building A – Shengda Science Park, 310051 Hangzhou
Date d'introduction en bourse 2022-07-11

Symboles boursiers

Nom Symbole
Over The Counter HNGZY
Autres actions
Les investisseurs qui détiennent Hangzhou Tigermed Consulting Co., Ltd. ont également les actions suivantes dans leur portefeuille :
ACCORINVEST 24/29 144A
ACCORINVEST 24/29 144A Obligation
AIS-AIDXBGA5 DLA
AIS-AIDXBGA5 DLA ETF
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles. Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Mentions légales Protection des données Blog Communauté Retour d'information Changelog
Im App Store herunterladen Bei Google Play herunterladen
Tous droits réservés © LCP GmbH 2025